SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

BULL NASDAQ is trending due to significant selling pressure, widely attributed to year-end tax-loss harvesting and ongoing dilution from its SPAC structure. Community sentiment is deeply divided, with optimists pointing to Webull's strong profitability, user growth, and international expansion as a long-term opportunity, while frustrated bears highlight continuous price declines and question its ability to compete in the fintech brokerage sector.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as investors anticipate a potential rebound with the close of year-end tax loss selling, coupled with ongoing speculation about Elon Musk's future actions regarding X payments. The community shows a strong divide, with many asserting its status as the 'King meme coin' and envisioning significant price appreciation, while others express skepticism about its immediate trajectory.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following the FDA approval of tradipitant for motion sickness, marking the first new treatment in decades. This milestone, combined with promising Phase 2 data showing tradipitant's efficacy in reducing GLP-1 induced nausea and vomiting, has ignited widespread community discussion about its significant potential in a rapidly expanding market. Investors are also keenly anticipating upcoming regulatory decisions for other pipeline candidates, fueling speculation about substantial growth and future acquisition interest.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind Corp is trending following the recent FDA approval of FUROSCIX for pediatric use and new patents issued for its ReadyFlow Autoinjector, which the community views as a significant advancement for at-home fluid management. While optimism surrounds these developments and the anticipated Afrezza launch in India, a persistent debate centers on current management's ability to translate product success into substantial long-term shareholder value.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding is trending due to its recent loan agreement, which aims to secure capital without immediate equity dilution, and the planned distribution of a "Dream Bowl 2026 Meme Coin" dividend tied to its Datavault AI partnership. Community sentiment is highly polarized: many foresee a significant short squeeze and value creation from tokenization and potential asset sales, while a vocal segment views these developments as further distractions by a management team perceived as eroding shareholder value. The broader context involves the company's foray into AI-driven Real-World Asset tokenization, alongside ongoing scrutiny of its core biotech pipeline.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics is surging with immense trading volume following news of a proposed business combination with Applied Digital's cloud division, forming an AI compute platform called ChronoScale. This pivot into AI infrastructure, combined with the stock's low float, is driving aggressive price action and high price targets among community members. However, some discussions highlight potential significant dilution for existing shareholders, creating a divided outlook on its long-term implications amidst the short-term volatility.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is experiencing significant volatility and increased trading activity as the anticipated FDA decision for its Relacorilant treatment for Cushing's Syndrome approaches. A sharp price decline fuels community fears of potential regulatory hurdles and whispers of a Complete Response Letter, while many longs emphasize the company's robust pipeline and accuse shorts of manipulation, making its near-term outlook a major point of contention.

Function is building the financial infrastructure that makes Bitcoin productive, unlocking yield, liquidity, and capital efficiency for holders across DeFi and traditional finance. FBTC turns Bitcoin into an asset that works.  FBTC represents the first omnichain Bitcoin yield asset, enabling BTC holders to participate in structured, risk-managed and programmatic yield strategies. FBTC is fully backed on a 1:1 basis with BTC, Bitcoin Reserve Address List is public and can be verified at any time. FBTC combines the security of Bitcoin reserves with the flexibility of smart contracts, creating a secure and efficient bridge between the Bitcoin network and modern DeFi protocols.  FBTC turns idle BTC into a functional and productive asset. The primary purpose of FBTC is to bring native Bitcoin liquidity into DeFi. Enabling Bitcoin holders to access a wide range of yield generating strategies, without having to sell their BTC. This not only enhances the utility of BTC but also allows holders to earn returns on their assets, making FBTC a powerful tool for maximizing the potential of Bitcoin in the DeFi ecosystem

Function ƒBTC

FBTC is trending amid ongoing volatility in the Bitcoin ETF market, characterized by recent outflows followed by a modest reversal of inflows. The community remains sharply divided, with some anticipating a prolonged "crypto winter" and further declines, while others maintain a bullish long-term outlook, emphasizing Bitcoin's historical resilience against market fluctuations.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

Ongoing CME margin hikes and impending Chinese export restrictions are driving significant volatility and intense debate around SLV. The community is sharply divided between those anticipating a continued silver squeeze fueled by industrial demand and those fearing market manipulation and a potential sharp pullback in the highly contested paper market.

iShares Bitcoin Trust ETF - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending amid notable Bitcoin volatility and a mixed outlook driven by fluctuating ETF inflows and the impending Bank of Japan rate decision. The community is sharply divided between those anticipating a prolonged 'crypto winter' and others who see the current dips as a prime 'buy the dip' opportunity driven by continued whale accumulation and institutional interest. This divergence in sentiment underscores the ongoing debate about Bitcoin's predictable cyclical behavior versus its increasing integration into traditional finance through instruments like IBIT.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What Fueled Inspire Veterinary Partners' (IVP) 27% After-Hours Rally?

Inspire Veterinary Partners shares jumped 27% after the company announced a consulting agreement issuing 9.45 million shares to 622 Capital.read more...

Zacks Initiates Coverage of Inspire Veterinary With Underperform Recommendation

Find out why Zacks assigns an "Underperform" rating to Inspire Veterinary, being the first on Wall Street to initiate coverage on the stock. Explore how steep losses, funding risks, and weak revenue trends challenge its ambitious expansion and new digital ventures.

<ul class="summary-bullets"><li>Inspire Veterinary Partners has received a formal warning from Nasdaq’s Listing Qualifications Department.</li><li>Inspire is ineligible for any cure period because of its reverse stock splits totaling a ratio of 250-to-1.</li><li>For the third-quarter, the company’s revenue rose by 7% year-on-year.</li></ul>Inspire Veterinary Partners (IVP) stock gained spotlight on Monday amid a potential delisting possibility after receiving a formal warning from Nasdaq’s Listing Qualifications Department.Inspire Veterinary Partners owns and operates animal care clinics across the United States.<h2 class="st-heading-2">Nasdaq Warning</h2>On Nov, 13, 2025, the company was notified that its common stock failed to maintain the required minimum bid price over 30 consecutive business days, putting it in violation of the Nasdaq Listing Rule.&nbsp;The notice also cited that Inspire is ineligible for any cure period because it has carried out reverse stock splits totaling a ratio of 250-to-1 or more over the past two years.<a href="https://stocktwits.com/symbol/IVP">Inspire Veterinary Partners’ stock</a> traded over 52% higher in Monday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;<h2 class="st-heading-2">Risk of Suspension</h2>The notification said that unless Inspire appeals to Nasdaq’s Hearings Panel by Nov. 20, 2025, its shares may be suspended from trading beginning Nov. 24, 2025.&nbsp;Earlier in 2025, Inspire completed a 1-for-25 reverse stock split, a move likely made to help lift its share price above the minimum threshold. The company has also carried out a prior 1-for-100 split in May 2024.&nbsp;For the third quarter, the company’s revenue rose by 7% year-on-year (YoY) to $4.3 million, net losses fell by 27% YoY, and revenue at comparable clinics grew 9.2% YoY.In October, Inspire Veterinary announced the launch of an online pet pharmacy to give veterinarians and pet owners access to a wide range of prescription and over-the-counter pet care products.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/quantum-enabled-drones-ion-q-and-heven-forge-defense-alliance/cL5b7ASREQI">Quantum-Enabled Drones: IonQ And Heven Forge Defense Alliance</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A German Shepherd, which San Francisco Animal Care and Control suspect was used as bait in pit bull fights, is assisted in lying down by Debbie Utter, veterinary technician.

Why Is IVP Stock Drawing Investor Attention Today?

Inspire Veterinary Partners has received a formal warning from Nasdaq’s Listing Qualifications Department.

Equity

On Nov. 13, 2025, the company was notified that its common stock failed to maintain the required minimum bid price.


Inspire Veterinary Partners, Inc. engages in the business of operating small animal general practice hospitals which serve all manner of companion pets, emphasizing canine, and feline breeds and including equine care. The firm is also involved in acquiring additional veterinary hospitals including general practice, mixed animal facilities, and critical and emergency care. The company was founded on December 2, 2020 and is headquartered in Virginia Beach, VA.

IVP
Inspire Veterinary Partners Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Fundamentals

Info

Latest IVP News

IVPInspire Veterinary Partners Inc. - Ordinary Shares - Class A